THE CARER | MAY/JUNE 2021 | PAGE 27
HYGIENE & INFECTION CONTROL CleanRite, Proves Efficacy of Hypochlorous Against SARS-CoV-2 to Offer New Generation of Alcohol-Free Sanitisers Launching in the UK CleanRite sanitisers, a new dermatologically advanced solution to keeping surfaces and hands guarded against COVID-19 is launching in the UK in April 2021. CleanRite is a new generation disinfectant range to ensure surfaces, the air in areas such as care homes, as well as hands - are all protected from the SARS-CoV-2 virus.
THE ‘WONDER’ OF HYPOCHLOROUS The CleanRite range of sanitising products are Hypochlorous-based (HOCl) which is an anti-viral, anti-fungal, anti-bacterial solution, proven to kill 99.9% of germs on contact. Specifically, Hypochlorous has been proven effective against SARS-CoV-2 in an independent lab test carried out by Richard Stanton, a Reader in Division of Infection & Immunity at the School of Medicine at Cardiff University. Fully regulated and child-friendly, CleanRite, which dries quickly and leaves no sticky residue, is perfect for use in care homes - as well as being dermatologically tested and suitable for use from birth. Caroline Fogarty, Managing Director, CF Pharma, said, “In laboratory tests we were able to show that the Hypochlorous ingredient in CleanRite killed the SARS-CoV-2 virus within 30 seconds. Hypochlorous is a ‘wonder’ ingredient because not only is it free of alcohol and harmful chemicals, it is hypoallergenic and skin friendly. It is as natural as water and doesn’t need to be rinsed off. So not only is it people-friendly, but it is planet-friendly too. “I believe that Hypochlorous is the future of everyday sanitisation. As we learn to live with the need for heightened sanitisation even after lockdown is eased, choosing something that is gentle on your skin, eyes, lungs and even the environment makes CleanRite ideal for long-term usage.”
CLEANRITE – BOTH POWERFUL AND SAFE CleanRite is an alcohol-free hypoallergenic sanitiser. It is highly effective without dehydrating, irritating, stinging or damaging skin or eyes making it perfect for all skin types, including sensitive skin. CleanRite is highly effective on multiple surfaces and equipment including kitchen worktops (since it is food safe). And unlike most alcohol-based products, CleanRite is non-flammable. Clare Hughes (MPSI BSc PHARM), Founder, CF Pharma said, “The advanced CleanRite formulation based on Hypochlorous, makes this ‘nature’s powerful disinfectant’. Indeed, Hypochlorous, which is produced naturally by the body’s white blood cells to support the human immune system in fighting infection and bacteria, has been used in wound-healing for decades.” Caroline Fogarty said, “It looks like we are going to be living with the need for increased sanitisation for some considerable time. So being able to offer a sanitisation range that has a skin friendly pH for family use, from birth, makes CleanRite an essential tool for everyone as we navigate the new normal.”
AVAILABILITY CleanRite is manufactured in various sizes from 60ml to 4500ml with convenient 60ml and 150ml finger sprays for travel available, which are for sale on Amazon For further information, to view the full range of products or to place an order for your business, visit CleanRite CF Pharma http://cleanrite.ie
Fellowes Aeramax Pro Air Purifiers Certified to Remove 99.9% of Airborne Coronavirus and H1N1 Flu Leading commercial air purification manufacturer, Fellowes, is pleased to announce its AeraMax Pro air purifiers have shown a 99.99% airborne reduction of a coronavirus surrogate within 60 minutes of operation. With the recent, intensified focus on the reduction of airborne transmission of viruses, a number of worldwide bodies including the Centers for Disease Control and Prevention (CDC), ASHRAE, as well as ‘healthy building’ scientific advocates, have recommended that portable air cleaners using HEPA filtration can help in the protection against SARS-Cov-2. This is particularly key for settings such as care homes, where occupants have an increased level of vulnerability to the spread of disease and therefore require this additional protection. In response to this, air purification expert, Fellowes recently arranged for its AeraMax Pro purifier, which has a four-stage TRUE HEPA filtration system, to be independently tested for efficacy in the reduction of two of the most healththreatening airborne-transmitted contaminants seen in recent times – coronavirus and the H1N1 virus.
UK Care Homes Use Groundbreaking Health Technology to Maintain Clean Air and Surfaces
Care home owners have been among the first customers to purchase air and surface sterilisation products from Medklinn, the international health technology company, which recently launched in the UK. Following confirmation from scientists from Fujita Health University in Japan, that low concentrations of ozone gas can be used to neutralise coronavirus particles without causing harm to humans, UK care homes have an alternative method to sterilise the air and surfaces in their premises without the use of chemicals. According to the university research, low-level ozone gas in concentrations of 0.05 to 1.0 parts per million (ppm) could be key to neutralising the spread of coronavirus in healthcare settings such as examination rooms and waiting areas. Medklinn International, the health technology company that has pioneered research and development into negative ionisation and ozone in the sterilisation process, already provides air and surface sterilisation solutions in ASIA, the USA, Canada, Australia and Germany. Now the business has launched in the UK. Daniel Lu, chief technology and innovation officer of Medklinn International, said: “We are pleased to be bringing our health technology to the UK. The announcement from the team at Fujita Health University in Japan further demonstrates that ozone sterilisation technology is a viable alternative to the use
of chemicals for disinfection.” In addition to the latest breakthrough in neutralising coronavirus particles, Medklinn products are also proven to be effective in: • Killing 99.9% of harmful microorganisms such as viruses and bacteria, mould and fungi by destroying their RNA and DNA structure • Eliminating volatile organic compounds (VOCs), including those with adverse health effects • Neutralising allergenic organic compounds such as pet dander and the protein in the faeces of dust mites, which are often the cause of allergies Steve Jones, Brand Manager Medklinn UK, said: “We’re really excited to be launching Medklinn UK. Our products are already used by some of the leading global brands in the healthcare, travel and tourism, retail, education, F&B and hospitality sectors, including Hyatt, Mandarin Oriental and Singapore’s Changi Airport. We believe that they will be particularly useful as we make gradual steps towards easing restrictions and reopening the UK following the lockdowns over the past 12 months.” Medklinn UK offers a consumer range of products suitable for the home and for use in vehicles. It also offers a range of air and surface sterilisers designed for business use including: • Permanent units for spaces up to 1,000 sq ft such as hotel guest rooms, washrooms, offices and classrooms • Permanent units for large spaces of 3,000 sq ft or more such as hotel corridors, washrooms, restaurants, halls, offices, exhibition centres, supermarkets, food processing and manufacturing plants • Portable units for ad hoc treatments of indoor odours recommended for hotel guest rooms, restaurants and facilities management It will also offer ozone water systems (for washrooms, industrial kitchens, food processing factories) and integrated sterilisation systems (for public washrooms, food processing and F&B outlets and supermarkets). For further information about Medklinn UK please visit uk.medklinn.com or contact medklinn@tunnelight.net.
Certified by Shanghai WEIPU Chemical Technology Service Company, Fellowes AeraMax Pro air purifiers demonstrated effectiveness in reducing the aerosolised airborne concentration of Human Coronavirus 229E in a test chamber, reaching 99.99% airborne reduction within one hour of operation. As it is not yet possible, or ethically responsible to aerosolise Sars-CoV-2 for airborne testing in the current climate, the coronavirus 229E was used as a surrogate to SarsCoV-2. Furthermore, AeraMax Pro air purifiers have also been proven to remove 99.9% of the H1N1 virus within 35 minutes of operation, as certified by Airmid Health Group Limited in Dublin, Ireland. When installed in a care home environment, AeraMax Pro therefore offers outstanding protection against the transmission of coronavirus 229E and the H1N1 virus between staff, visitors and vulnerable residents. For more information about Fellowes AeraMax Pro air purifiers, visit www.aeramaxpro.com/uk